HeSANDA Clinical Trials

Building national infrastructure for clinical trials data sharing and collaboration
The patient boy is happy in the hospital, He has a cheerful hear
Who will benefit
Australia’s health research and clinician community

The Challenge

Enabling access and reuse of clinical trials data allows for better insights about the effectiveness of health interventions and therapies, which allows for health guidelines and treatments to be improved as exemplified by the collaborative response to the COVID-19 pandemic.

While the potential benefits are significant, as is the case with most health data, the sharing and reuse of clinical trials data are limited by the diverse approaches to data governance and management used by trials in Australia.

The Response

The Health Studies Australian National Data Asset (HeSANDA) program is building national infrastructure to allow researchers to access and share data from health studies, including clinical trials, cohort studies and other data valuable for research.

Our HeSANDA Clinical Trials projects focus on enabling researchers to share and find investigator-initiated and academic clinical trial data. The projects are delivered in partnership with the Australian clinical trials community, which is working together to develop and implement national data standards.

The major output from the partnership is Health Data Australia – a new online portal to help researchers access that data.

How was HeSANDA Clinical Trials established?

Extensive consultation with the research community and key stakeholders identified priorities, requirements, and guiding principles for a new national research infrastructure.

The first consultations were completed in August 2020, and the outcomes of these consultations are detailed in the Development Priorities Consultation Report. These set the direction of the asset based on the data development principles.

A second round of consultations were held with key stakeholders: clinical trialists, research participants, and health consumers. These workshops validated and refined HeSANDA’s approach. The outcomes are detailed in the Stakeholder Consultation Report.

Based on these consultations, we established partnerships with research institutions, organisations and other stakeholders involved in clinical trials research around Australia. These partnerships established the 9 HeSANDA nodes, which represent 72 research organisations across Australia.

We work together to build national capability in the 3 key areas:

Coherent data practices

Research community and stakeholder-defined data sharing practices for minimum information requirements, metadata design, data access, and ethics and consent

Coordinated data services

A national network of infrastructure nodes supplying clinical trials metadata and research outputs according to the coherent data practices

Federation services

Interfaces, applications, and services that allow research and data discovery, data request and access, and additional functionality across the node network

As part of the People Research Data Commons, the second stage of the HeSANDA Clinical Trials partnership involves transitioning the HeSANDA infrastructure into its operational phase.

The People Research Data Commons is also establishing projects to extend the clinical trials data approach to other health study types, such as cohort studies, and deploy new capabilities such as secure access environments.

Outcomes

The key outcome from the project is Health Data Australia – a catalogue for health and medical researchers to register a description of their research so it’s easy to discover. 

A federated structure of partners across Australia then links researchers and facilitates data sharing and data access. This is possible through the searchable online catalogue and a data access request portal.

Importantly, the researchers who created the data always maintain control over their data and determine with whom it is shared.

Other outcomes of this project include:

Expected outcomes of the second stage

The expected outcomes from the second phase of the HeSANDA Clinical Trials partnership include:

  • improving the quality, scalability and sustainability of Nodes’ local infrastructure (including policies, procedures, and systems)
  • increasing the buy-in and uptake of HeSANDA Node infrastructure from partner organisations and clinical trials
  • aligning and coordinating activity across the HeSANDA Node network as a whole.

Value of HeSANDA and Health Data Australia

Overall, this activity increases Australia’s return on investment in health and medical research by enabling researchers to reuse existing data to inform new research questions and initiate new research collaborations. This will accelerate research answers and extend the value of consumer/participant contributions in a systematic and meaningful way.

Here is the value of HeSANDA and Health Data Australia for health researchers, the research ecosystem and the community:

Research participants and the community

  • allows participants to contribute to more research without requiring more of their time or effort
  • makes the most out of the data that participants provide
  • participants may view this as a meaningful contribution to more than one research project.

Health services

  • supports improved research practices in health services
  • raises the profile, status and researcher reputation through increased citations, collaborations and grant applications
  • increases the use of research data that has been created and supported through health service funding.

Research organisations

  • raises the profile, status, research reputation and ranking of institutions and the researchers through increased citations, collaborations and grant applications
  • creates more opportunity for impactful projects
  • enhances research rigour, i.e. by making research easier to reproduce
  • increases productivity through the increase in the number of research outputs
  • could lead to a positive impact on the number of students, commercialisation and quality and value of research grants.

Researchers creating data (data providers)

  • provides a systematic approach for researchers across Australia to:
    • gain increased recognition and visibility for their research
    • extend the life of their research
    • meet their responsibilities to share data from publicly funded research projects
    • facilitate new collaborations to expand their research impact

It is anticipated that this will lead to:

  • increased ability to understand and answer specific questions and generate new hypotheses
  • more publications and citations, new students, successful grants and a sense of helping others across the country
  • better access to guidance, standards and governance around data sharing.

Researchers seeking data (data users)

  • inspires new research questions and provides opportunities to build richer and more extensive datasets
  • provides a systematic and clear mechanism to create new collaborations
  • reduces research costs and duplication and saves time by hosting a catalogue of available research in one place and a clear pathway to request data
  • accelerates research discovery.

Funders

  • increases the return on investment through the reuse of research data
  • could lead to a positive impact on the value of the research grant and enhanced awareness of the funding body.

The Partners

The ARDC has established a network of 9 infrastructure nodes representing 72 research organisations, covering the majority of Australia’s states, territories, and health researchers. These organisations are working together to deliver coherent data practices and coordinated data services at a national scale.

The HeSANDA nodes are:

  • The University of Melbourne (administering organisation)
  • Austin Health
  • BioGrid Australia
  • Centre for Eye Research Australia
  • Murdoch Children’s Research Institute & Royal Children’s Hospital
  • Northern Health
  • PeterMac Cancer Centre
  • St Vincent’s Hospital Melbourne
  • The Royal Melbourne Hospital
  • Western Health

  • Deakin University (administering organisation)
  • Australian Early Psychosis Collaborative Consortium
  • Barwon Health
  • Orygen
  • The University of Melbourne

  • Monash University (administering organisation)
  • Monash Partners

  • Australasian Leukaemia and Lymphoma Group (ALLG) (administering organisation)
  • Australian & New Zealand Children’s Haematology/Oncology Group (ANZCHOG)
  • Australasian Gastro-Intestinal Trials Group (AGITG)
  • Australia and New Zealand Sarcoma Association (ANZSA)
  • Australia New Zealand Gynaecological Oncology Group (ANZGOG)
  • Australian & New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
  • Breast Cancer Trials
  • Cancer Symptom Trials (CST) and Palliative Care Clinical Studies Collaborative (PaCCSC)
  • Cooperative Trials Group for Neuro-Oncology (COGNO)
  • Melanoma and Skin Cancer Trials (MASC Trials)
  • Primary Care Collaborative Cancer Clinical Trial Group (PC4)
  • Psycho-oncology Co-operative Research Group (PoCoG)
  • Thoracic Oncology Group of Australasia (TOGA)
  • Trans-Tasman Radiation Oncology Group (TROG)

  • Menzies School of Health Research (administering organisation)
  • Charles Darwin University

  • Health Translation Queensland (administering organisation)
  • AARNet
  • Australasian Kidney Trials Network
  • Brisbane Diamantina Health Partners
  • Cairns and Hinterland Hospital and Health Service
  • Central Queensland University
  • Children’s Health Queensland Hospital and Health Service
  • CSIRO’s Australian e-Health Research Centre
  • Griffith University
  • James Cook University
  • Mackay Hospital and Health Service
  • Mater Misericordiae Ltd
  • QIMR Berghofer Medical Research Institute
  • QCIF
  • Queensland Government Department of Health
  • Queensland Government Metro North Hospital and Health Services
  • QUT
  • The University of Queensland
  • Townsville Hospital and Health Service
  • Tropical Australian Academic Health Centre Ltd
  • University of the Sunshine Coast
  • University Southern Queensland

  • South Australian Health and Medical Research Institute (SAHMRI) (administering organisation)
  • Flinders University
  • Health Translation SA

  • NHMRC Clinical Trials Centre at The University of Sydney (administering organisation)
  • Cardiovascular Centre of Excellence
  • Digital Health CRC
  • Institute for Musculoskeletal Health
  • Institute of Bone and Joint Research
  • Sydney Children’s Hospitals Network
  • Sydney Health Partners
  • Sydney Local Health District
  • The Brain and Mind Centre
  • The Matilda Centre
  • University of Sydney
  • Westmead Applied Research Centre
  • Westmead Institute for Medical Research
  • Woolcock Institute for Medical Research

  • Curtin University (administering organisation)
  • Child and Adolescent Health Service
  • Ear Science Institute Australia
  • Edith Cowan University
  • Government of Western Australia East Metropolitan Health Service
  • Government of Western Australia North Metropolitan Health Service
  • Government of Western Australia South Metropolitan Health Service
  • Harry Perkins Institute of Medical Research
  • Institute of Respiratory Health
  • Lions Eye Institute
  • Murdoch University
  • The University of Western Australia
  • WA Country Health Service
  • WA Health Translation Network

Read the HeSANDA flyer

Learn more about HeSANDA, its value, how it works and the HeSANDA network from this flyer.

Timeframe

June 2020 to June 2026

Current Phase

In progress

Project lead

Kristan Kang, ARDC